ACES GmbH
Home

Blueprints of the Future

The master plan of nature is ingenious and simple at the same time. Higher, faster, further. We experience it daily: The evolution in time lapse. R&D services by ACES GmbH.

Welcome to ACES

ACES is the abbreviation for Advanced Consulting & Engineering Services and describes our services in four words: We are an engineering service provider for various sectors, with our main focus on medical devices (spine). In the past 15 years we have developed and tested a broad portfolio of successful implants mainly for fusion treatments of the spine on behalf of leading medical device companies and in close cooperation with renowned surgeons worldwide. Current developments are mainly related to the area of dynamic stabilization of the spine (interspinous, posterior, intervertebral) as well as the non-fusion treatment of scoliosis. More about us

Our History

ACES GmbH was formed in 1999 out of the engineering firm Trautwein engineering, which was founded in 1994 in Stuttgart, Germany. The business activities were the provision of engineering services like the development, design and simulation of components or assemblies using the latest ...read more

Philosophy

Our mission is to develop medical implants and surgical techniques in order to treat diseases of the spine and joints. It is our business to challenge concepts, designs and strategies. However, there are a few cornerstones in our daily work that founded our success. In ...read more

News Search

  • Latest News

  • 25.08.2010, Medyssey Spine Receives F ...

    LOS ANGELES, Aug. 25 /PRNewswire/ -- South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Admin ...

  • 25.08.2010, Medyssey Spine Receives F ...

    LOS ANGELES, Aug. 25 /PRNewswire/ -- South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Admin ...

  • 25.08.2010, Medyssey Spine Receives F ...

    LOS ANGELES, Aug. 25 /PRNewswire/ -- South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Admin ...